GM-CSF is used as an immunostimulant in cancer therapy, as an adjuvant in vaccines, and the results of the clinical trial have shown that GM-CSF-based gene therapy is an ideal approach to improve treatment outcomes in melanoma [52]. This evidence concerns the gene CSF2 and cancer.